产品封面图

Phospho-CDC20 (Ser51) Antibody

收藏
  • 询价
  • Cell Signaling Technology已认证
  • USA
  • 2025年10月12日
  • W, IP
  • Rabbit
  • H,M,R
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 抗体英文名

      Phospho-CDC20 (Ser51) Antibody

    • 抗原

      synthetic peptide corresponding to residues surrounding Ser51 of human CDC20 protein

    • 应用范围

      W, IP

    • 宿主

      Rabbit

    • 库存

      大量

    • 供应商

      CST

    • 级别

      详见MSDS文件

    • 适应物种

      H,M,R

    • 保质期

      详见说明书

    • 是否单克隆

      2

    • 保存条件

      -20°c

    • 规格

      100 ul (10 western blots)/carrier free & custom formulation / quantity

    规格:产品价格:¥请询价
    规格:100 ul (10 western blots)产品价格:¥请询价
    规格:carrier free & custom formulation / quantity产品价格:¥请询价

    pathway more info application references datasheet PDF MSDS PDF protocols

    Applications Key:  W=Western Blotting  IP=Immunoprecipitation
    Reactivity Key:  H=Human  M=Mouse  R=Rat
    Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

    Applications Reactivity Sensitivity MW (kDa) Source
    W IP H M (R) Endogenous 51 Rabbit
    Protocols
    Specificity / Sensitivity

    Phospho-CDC20 (Ser51) Antibody recognizes endogenous levels of CDC20 protein only when phosphorylated at Ser51.

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser51 of human CDC20 protein. Antibodies are purified by protein A and peptide affinity chromatography.

    Western Blotting

    Western Blotting

    Western blot analysis of extracts from 293T cells, untreated (-) or treated (+) with λ phosphatase, using Phospho-CDC20 (Ser51) Antibody (upper) and CDC20 Antibody #4823 (lower).

    Background

    The cell division cycle demands accuracy to avoid the accumulation of genetic damage. This process is controlled by molecular circuits called "checkpoints" that are common to all eukaryotic cells (1). Checkpoints monitor DNA integrity and cell growth prior to replication and division at the G1/S and G2/M transitions, respectively. The cdc2-cyclin B kinase is pivotal in regulating the G2/M transition (2,3). Cdc2 is phosphorylated at Thr14 and Tyr15 during G2-phase by the kinases Wee1 and Myt1, rendering it inactive. The tumor suppressor protein retinoblastoma (Rb) controls progression through the late G1 restriction point (R) and is a major regulator of the G1/S transition (4). During early and mid G1-phase, Rb binds to and represses the transcription factor E2F (5). The phosphorylation of Rb late in G1-phase by CDKs induces Rb to dissociate from E2F, permitting the transcription of S-phase-promoting genes. In vitro , Rb can be phosphorylated at multiple sites by cdc2, cdk2, and cdk4/6 (6-8). DNA damage triggers both the G2/M and the G1/S checkpoints. DNA damage activates the DNA-PK/ATM/ATR kinases, which phosphorylate Chk at Ser345 (9), Chk2 at Thr68 (10) and p53 (11). The Chk kinases inactivate cdc25 via phosphorylation at Ser216, blocking the activation of cdc2.

    CDC20 binds to and activates the anaphase-promoting complex (APC) during mitosis and G1 phase of the cell cycle (12). Moreover, CDC20 is necessary for ubiquitin ligase activity of the APC/cyclosome (APC/C). In metaphase MAD2L1 inactivates the CDC20-APC/C complex, while in anaphase this inhibition is lost and CDC20-APC/C degrades its substrates (13). p53 and p21 suppress expression of CDC20 upon genotoxic stresses and ectopic introduction of p53. siRNA mediated knock-down of CDC20 in cancer cells leads to attenuated cell growth and induces G(2)/M arrest, suggesting that CDC20 is a possible therapeutic target of cancer (14). Organization of neuronal circuits requires presynaptic axonal differentiation and synapse formation. CDC20-APC regulates presynaptic differentiation in postmitotic neurons by triggering the required degradation of the transcription factor NeuroD2 (15). Phosphorylation of CDC20 at Ser51 by CAMKIIβ disperses CDC20 from the centrosome. As a result, CDC20-APC activity is inhibited and transition from growth to retraction of dendrites in primary neurons is triggered (16).

    1. Nurse, P. (1997) Cell 91, 865-7.
    2. Norbury, C. and Nurse, P. (1992) Annu Rev Biochem 61, 441-70.
    3. Watanabe, N. et al. (1995) EMBO J 14, 1878-91.
    4. Sherr, C.J. (1996) Science 274, 1672-7.
    5. Dyson, N. (1998) Genes Dev 12, 2245-62.
    6. Kitagawa, M. et al. (1996) EMBO J 15, 7060-9.
    7. Lundberg, A.S. and Weinberg, R.A. (1998) Mol Cell Biol 18, 753-61.
    8. Harbour, J.W. et al. (1999) Cell 98, 859-69.
    9. Zhao, H. and Piwnica-Worms, H. (2001) Mol Cell Biol 21, 4129-39.
    10. Matsuoka, S. et al. (2000) Proc Natl Acad Sci USA 97, 10389-94.
    11. Tibbetts, R.S. et al. (1999) Genes Dev 13, 152-7.
    12. Fang, G. et al. (1998) Mol Cell 2, 163-71.
    13. Fang, G. et al. (1998) Genes Dev 12, 1871-83.
    14. Kidokoro, T. et al. (2008) Oncogene 27, 1562-71.
    15. Yang, Y. et al. (2009) Science 326, 575-8.
    16. Puram, S.V. et al. (2011) Nat Neurosci , .
    Application References

    Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know !

    Companion Products

    For Research Use Only. Not For Use In Diagnostic Procedures.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3662
    北京智杰方远科技有限公司
    2025年11月16日询价
    询价
    美国CST中国公司(丁香通商铺)
    2024年10月27日询价
    询价
    上海抚生实业有限公司
    2026年03月08日询价
    ¥3886
    武汉博欧特生物科技有限公司
    2025年05月04日询价
    ¥500
    北京百奥创新科技有限公司
    2025年03月17日询价
    Phospho-CDC20 (Ser51) Antibody
    询价